Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 3 4Phase 2 3Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Erectile Dysfunction 1

Interventions

Oxaliplatin 21Capecitabine 17Fluorouracil 15Irinotecan 11Radiotherapy 10Leucovorin 8Cetuximab 6Bevacizumab 6Gemcitabine 5oblimersen 3fludarabine 3aldesleukin 3Nivolumab 3Erlotinib Hydrochloride 3Cyclophosphamide 3labetuzumab 2dehydroftorafur 2conatumumab 2Tomography, X-Ray Computed 2Receptor Protein-Tyrosine Kinases 2Radiation 2Panitumumab 2Neoadjuvant Therapy 2Magnetic Resonance Imaging 2Interleukin-2 2Gefitinib 2Electrocardiography 2Diphenhydramine 25,10-methylenetetrahydrofolic acid 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Rectal Neoplasms × Laparoscopy × Clear all
NCT02648386 2019-01-25

Stem Cell Therapy Combined With NeuroRegen Scaffoldâ„¢ in Patients With Erectile Dysfunction After Rectal Cancer Surgery

Chinese Academy of Sciences

Phase 1/2 Unknown
34 enrolled
Gastrointestinal

Erectile Dysfunction, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡